Interaction of Energy Drinks with Prescription Medication and Drugs of Abuse


Por: Hladun, O, Papaseit, E, Martin, S, Barriocanal, AM, Poyatos, L, Farre, M and Perez-Mana, C

Publicada: 1 oct 2021 Ahead of Print: 22 sep 2021
Resumen:
In recent years, the consumption of energy drinks (EDs) has become increasingly popular, especially among adolescents. Caffeine, a psychostimulant, is the main compound of EDs which also contain other substances with pharmacological effects. This review aims to compile current evidence concerning the potential interactions between EDs, medicines, and drugs of abuse as they are frequently consumed in combination. The substances involved are mainly substrates, inductors or inhibitors of CYP1A2, psychostimulants, alcohol and other depressant drugs. Furthermore, intoxications reported with EDs and other substances have also been screened to describe acute toxicity. The results of our review show that the consumption of both EDs alone and in combination is not as safe as previously thought. Health professionals and consumers need to be aware of the potential interactions of these drinks as well as the absence of long-term safety data.



Filiaciones:
Hladun, O:
 Hosp Badalona Germans Trias & Pujol, Inst Recerca Germans Trias & Pujol HUGTiP IGTP, Clin Pharmacol Unit, Badalona 08916, Spain

 Univ Autonoma Barcelona, Dept Pharmacol Therapeut & Toxicol, Cerdanyola Del Valles 08193, Spain

:
 Hosp Badalona Germans Trias & Pujol, Inst Recerca Germans Trias & Pujol HUGTiP IGTP, Clin Pharmacol Unit, Badalona 08916, Spain

 Univ Autonoma Barcelona, Dept Pharmacol Therapeut & Toxicol, Cerdanyola Del Valles 08193, Spain

Martin, S:
 Hosp Badalona Germans Trias & Pujol, Inst Recerca Germans Trias & Pujol HUGTiP IGTP, Clin Pharmacol Unit, Badalona 08916, Spain

:
 Hosp Badalona Germans Trias & Pujol, Inst Recerca Germans Trias & Pujol HUGTiP IGTP, Clin Pharmacol Unit, Badalona 08916, Spain

 Univ Autonoma Barcelona, Dept Pharmacol Therapeut & Toxicol, Cerdanyola Del Valles 08193, Spain

:
 Hosp Badalona Germans Trias & Pujol, Inst Recerca Germans Trias & Pujol HUGTiP IGTP, Clin Pharmacol Unit, Badalona 08916, Spain

 Univ Autonoma Barcelona, Dept Pharmacol Therapeut & Toxicol, Cerdanyola Del Valles 08193, Spain

:
 Hosp Badalona Germans Trias & Pujol, Inst Recerca Germans Trias & Pujol HUGTiP IGTP, Clin Pharmacol Unit, Badalona 08916, Spain

 Univ Autonoma Barcelona, Dept Pharmacol Therapeut & Toxicol, Cerdanyola Del Valles 08193, Spain

:
 Hosp Badalona Germans Trias & Pujol, Inst Recerca Germans Trias & Pujol HUGTiP IGTP, Clin Pharmacol Unit, Badalona 08916, Spain

 Univ Autonoma Barcelona, Dept Pharmacol Therapeut & Toxicol, Cerdanyola Del Valles 08193, Spain
ISSN: 19994923





Pharmaceutics
Editorial
Multidisciplinary Digital Publishing Institute (MDPI), ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND, Suiza
Tipo de documento: Review
Volumen: 13 Número: 10
Páginas:
WOS Id: 000711912400001
ID de PubMed: 34683828
imagen gold, Green Published

MÉTRICAS